FABP4 and type 2 diabetes mellitus: Also, it has been shown that the serum FABP4 is associated with myocardial neutral lipid content in patients with type 2 diabetes mellitus (T2DM), where FABP4 has been found to induce insulin resistance by increasing the intracellular lipid contents [10].